CRISPR-Cas9

The treatment for Beta-Thalassemia is expected to cost $2.2 million and will be available in the United States this year.

A cutting-edge cure or CRISPR catastrophe? That's the question facing regulators.

Commentary In January, a group of scientists started working on clinical trials to cure sickle cell anemia, an ...

LONDON—A rogue Chinese scientist who caused outrage last year when he said he had created the world's first ...

A new kind of GMO is going by different names, and largely escaping regulation as it enters grocery ...